Judge Backs Acorda's $16.6M Award In MS Drug Row
A New York federal judge has confirmed a nearly $16.6 million arbitral award issued to Acorda Therapeutics Inc. in its dispute with Alkermes PLC over a multiple sclerosis drug, but refused to...To view the full article, register now.
Already a subscriber? Click here to view full article